Ownership history in MACQUARIE GROUP LTD · 21 quarters on record
This page tracks every 13F SEC filing in which MACQUARIE GROUP LTD reported a position in APELLIS PHARMACEUTICALS INC (APLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 65,156 | -139,647 | -68.2% | 0.00% | $1.5M | $22.63 |
| 2025 Q1 | ADDED | 204,803 | +3,736 | +1.9% | 0.01% | $4.5M | $21.87 |
| 2024 Q4 | ADDED | 201,067 | +17,778 | +9.7% | 0.01% | $6.4M | $31.91 |
| 2024 Q3 | REDUCED | 183,289 | -1,642 | -0.9% | 0.01% | $5.3M | $28.84 |
| 2024 Q2 | REDUCED | 184,931 | -36,723 | -16.6% | 0.01% | $7.1M | $38.36 |
| 2024 Q1 | REDUCED | 221,654 | -361,775 | -62.0% | 0.01% | $13.0M | $58.78 |
| 2023 Q4 | REDUCED | 583,429 | -493,119 | -45.8% | 0.04% | $34.9M | $59.86 |
| 2023 Q3 | ADDED | 1,076,548 | +301,068 | +38.8% | 0.05% | $41.0M | $38.04 |
| 2023 Q2 | REDUCED | 775,480 | -635,999 | -45.1% | 0.08% | $70.6M | $91.10 |
| 2023 Q1 | REDUCED | 1,411,479 | -50,163 | -3.4% | 0.10% | $93.1M | $65.96 |
As of 2025 Q4 — sorted by position size